Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Editors Pick

    Editors Pick - Page 30

    Dr Reddy

    Dr Reddy's Laboratories in process to seek permission for launch of 70 products in China

    Farhat Nasim3 Jun 2019 11:00 AM IST
    Dr Reddy's Chief Operations Officer, Erez Israeli in a recent earnings call said the drug-maker is in the process of seeking necessary approvals from...
    DTAB sub-committee to evaluate Fixed Dose Combination drugs considered irrational

    DTAB sub-committee to evaluate Fixed Dose Combination drugs considered irrational

    Farhat Nasim2 Jun 2019 2:40 PM IST
    New Delhi: The fate of Fixed Dose combinations considered irrational by the government have fallen once again in limelight as the Drugs Technical...
    Aster to enter diagnostics business in India with Aster Laboratories

    Aster to enter diagnostics business in India with Aster Laboratories

    Medical Dialogues Bureau2 Jun 2019 2:33 PM IST
    New Delhi: Healthcare services provider, Aster DM healthcare Thursday said it is entering into diagnostic services segment in India and plans to have...
    Apollo Hospitals Q4 revenue, Net Profit up, EBITDA crosses Rs 1000 crore milestone

    Apollo Hospitals Q4 revenue, Net Profit up, EBITDA crosses Rs 1000 crore milestone

    Medical Dialogues Bureau1 Jun 2019 2:36 PM IST
    Apollo Hospitals has delivered a strong performance in the final quarter of the year, with the continued growth of volumes, revenues and margins....
    Faulty hip implants Johnson and Johnson directed to pay Rs 25 Lakh to 67 patients who had revision surgery

    Faulty hip implants Johnson and Johnson directed to pay Rs 25 Lakh to 67 patients who had revision surgery

    Medical Dialogues Bureau31 May 2019 3:34 PM IST
    The Central Drugs Standard Control Organisation (CDSCO) had earlier asked the company Johnson and Johnson to pay Rs 65 lakh, Rs 74 lakh, Rs 1 crore...
    ResMed appoints Shubhi Khurana as New India, South Asia General Manager; to help increase awareness about sleep apnea

    ResMed appoints Shubhi Khurana as New India, South Asia General Manager; to help increase awareness about sleep apnea

    Farhat Nasim30 May 2019 9:30 AM IST
    Shubhi Khurana has more than two decades of experience in the pharmaceutical, healthcare, and medtech industries in various leadership roles.NEW...
    Ressurecting Sun Pharma: Shanghvi committed to pharma business; surrenders NBFC licence

    Ressurecting Sun Pharma: Shanghvi committed to pharma business; surrenders NBFC licence

    Meghna A Singhania29 May 2019 2:37 PM IST
    New Delhi: The billionaire entrepreneur, Dilip Shanghvi, founder of the 1983 established drug giant Sun Pharmaceuticals (Sun Pharma) is striving to...
    Technical Committee recommends CDSCO to approve import, marketing of Sanofi TB drug with clinical trial waiver

    Technical Committee recommends CDSCO to approve import, marketing of Sanofi TB drug with clinical trial waiver

    Farhat Nasim28 May 2019 4:21 PM IST
    New Delhi: Apex drug regulatory body, Central Drugs Standard Control Organization (CDSCO) has been recommended by the Techincal Committee to granted...
    Novartis wins USFDA approval for first PI3K inhibitor for breast cancer

    Novartis wins USFDA approval for first PI3K inhibitor for breast cancer

    Farhat Nasim27 May 2019 6:10 PM IST
    The drug, alpelisib, to be marketed under the brand name Piqray, belongs to a class of drugs known as PI3K inhibitors and is the first of its kind to...
    Dilip Shanghvi plans comeback; Sun Pharma to develop its own medicines: Report

    Dilip Shanghvi plans comeback; Sun Pharma to develop its own medicines: Report

    Meghna A Singhania26 May 2019 6:13 PM IST
    Shanghvi estimates that Sun Pharma has invested about $1 billion in its patented-drug programme so far. He says growth in the Indian generics...
    Sun Pharma submits proposal to CDSCO for manufacturing, marketing FDC to treat URTI; Details

    Sun Pharma submits proposal to CDSCO for manufacturing, marketing FDC to treat URTI; Details

    Meghna A Singhania25 May 2019 11:15 AM IST
    New Delhi: Dilip Shanghvi led Sun Pharma recently submitted a proposal to seek permission from the national regulatory authority, Central Drugs...
    Procedure for approval of FDC drugs: CDSCO releases notification; Details

    Procedure for approval of FDC drugs: CDSCO releases notification; Details

    Meghna A Singhania24 May 2019 6:12 PM IST
    New Delhi: Through a recent notification, the Central Drugs Standard Control Organization (CDSCO) has directed drug manufacturers and all the...
    PrevNext

    Popular Stories

    India should become self-reliant in medical equipment, devices: Kasturirangan

    India should become self-reliant in medical equipment, devices: Kasturirangan

    Lupin gets USFDA EIR for Nagpur Facility

    Lupin gets USFDA EIR for Nagpur Facility

    Indira IVF to invest Rs 80 crore to expand presence in south India by 2020

    Indira IVF to invest Rs 80 crore to expand presence in south India by 2020

    Shipment of  antimalarial drug to US is likely to start next week: Indian Pharmaceutical Alliance

    Shipment of antimalarial drug to US is likely to start next week: Indian Pharmaceutical Alliance

    Lasa Supergenerics gets FDA nod for Progesterone

    Lasa Supergenerics gets FDA nod for Progesterone

    Wellthy Therapeutics announces Rs 30 crore financing round led by Saama Capital

    Wellthy Therapeutics announces Rs 30 crore financing round led by Saama Capital

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop production

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop...

    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok